Sign in

CIK 0001159036

  • Large accelerated filer

HALOZYME THERAPEUTICS, INC.

Sign in to watch
Ticker
HALO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
880488686
Phone
+1 858-794-8889
Business address
12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
Former names
HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$22,144,286
in 6 filings, $22.1M under 10b5-1 plans

Net −$22,144,286. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-06-07 Torley Helen President and CEO Sale −50,000 $39.66 $2.0M 537,160
2021-06-07 Torley Helen President and CEO Exercise or conversion · Option to Purchase Common Stock −50,000 $14.66 $733K 400,000
2021-05-11 Torley Helen President and CEO Exercise or conversion +50,000 $14.66 $733K 587,160
2021-05-11 Torley Helen President and CEO Sale −8,456 $42.17 $357K 578,704
2021-05-11 Torley Helen President and CEO Sale −36,522 $43.05 $1.6M 542,182
2021-05-11 Torley Helen President and CEO Sale −3,956 $44.11 $174K 538,226
2021-05-11 Torley Helen President and CEO Sale −1,066 $44.84 $48K 537,160
2021-05-11 Torley Helen President and CEO Exercise or conversion · Option to Purchase Common Stock −50,000 $14.66 $733K 450,000
2021-05-05 Posard Matthew L. Director Grant or award +5,230 128,983
2021-05-05 MATSUI CONNIE Director Grant or award +5,230 213,983
2021-05-05 Henderson Jeffrey William Director Grant or award +5,230 52,839
2021-05-05 Daly James M Director Grant or award +5,230 26,232
2021-05-05 Connaughton Bernadette Director Grant or award +5,230 32,013
2021-05-05 BIZZARI JEAN-PIERRE Director Grant or award +5,230 87,544
2021-05-03 LaBarre Michael J. SVP, Chief Technical Officer Exercise or conversion +11,311 $11.29 $128K 134,111
2021-05-03 LaBarre Michael J. SVP, Chief Technical Officer Exercise or conversion · Option to Purchase Common Stock −11,311 0
2021-04-14 Kelley Kenneth J Director Sale −5,000 $45.00 $225K 179,833
2021-04-05 Torley Helen President and CEO Exercise or conversion +50,000 $14.66 $733K 587,160
2021-04-05 Torley Helen President and CEO Sale −50,000 $42.55 $2.1M 537,160
2021-04-05 Torley Helen President and CEO Exercise or conversion · Option to Purchase Common Stock −50,000 $14.66 $733K 500,000

Page 50 of 59 · 1,177 trades